Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
987.9 DKK | -0.59% |
|
-0.31% | +41.51% |
09:45pm | Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says | RE |
02:16pm | Novo Nordisk Confirms WHO Coordination Amid Fake Ozempic Batches | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.51% | 633B | |
+51.39% | 798B | |
-5.08% | 356B | |
+19.37% | 328B | |
+10.51% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+7.66% | 166B | |
-3.82% | 157B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk's Ozempic Reduces Kidney Disease, Death Risk According to Study of Patients With Type 2 Diabetes